Acute leucoencephalomyelopathy and quadriparesis after CAR T-cell therapy
Haematologica
.
2021 May 1;106(5):1504-1506.
doi: 10.3324/haematol.2020.259952.
Authors
Ranjit Nair
1
,
Gaëlle Drillet
2
,
Faustine Lhomme
2
,
Anthony Le Bras
3
,
Laure Michel
4
,
John Rossi
5
,
Marika Sherman
5
,
Allen Xue
5
,
Anne Kerber
5
,
Nutchawan Jittapiromsak
6
,
Linda Chi
6
,
Sudhakar Tummala
7
,
Sattva S Neelapu
1
,
Roch Houot
2
Affiliations
1
Dept of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.
2
CHU Rennes, Department of Hematology, University of Rennes, Rennes, France.
3
CHU Rennes, Department of Radiology, University of Rennes, Rennes, France.
4
CHU Rennes, Department of Neurology, University of Rennes, Rennes, France.
5
Kite, a Gilead company, Santa Monica, California, USA.
6
Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, USA.
7
Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
PMID:
32732365
PMCID:
PMC8094092
DOI:
10.3324/haematol.2020.259952
No abstract available
MeSH terms
Humans
Immunotherapy, Adoptive
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
Quadriplegia / etiology
Quadriplegia / therapy
Receptors, Chimeric Antigen* / genetics
Substances
Receptors, Chimeric Antigen